Endocrine-disrupting chemicals -such as BPA-can show tangible effects on health endpoints at high dosage levels, yet those effects do not predict how EDCs will affect the endocrine system at low doses, according to a recent study accepted for publication in The Endocrine Society's Endocrine Reviews.
BPA shows tangible effects on health endpoints at high dosage levels